Cargando…
Epidemiological and survival outcomes of neuroendocrine carcinoma of the breast: a SEER data analysis
BACKGROUND: Neuroendocrine carcinoma of the breast (NECB) is a rare subtype of breast cancer, comprising only 0.1% to 5% of all breast cancer cases. Despite its rarity, it is important to gain a better understanding of the epidemiological, clinical, and prognostic features of NECB. The purpose of th...
Autores principales: | Xia, Longjie, Lai, Jianqin, Liu, Xiangxia, Kong, Fanbiao, Qiu, Shenghui, Hu, Huiqiong, Zhu, Shaoliang, Cao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493786/ https://www.ncbi.nlm.nih.gov/pubmed/37701099 http://dx.doi.org/10.21037/tcr-23-368 |
Ejemplares similares
-
Comparing the diagnostic efficacy of [(18)F]FDG PET/CT and [(18)F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
por: Xia, Longjie, et al.
Publicado: (2023) -
Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study
por: Zhou, Huaqiang, et al.
Publicado: (2017) -
Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database
por: Wang, Jun, et al.
Publicado: (2014) -
Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study
por: Li, Yu-feng, et al.
Publicado: (2020) -
Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study
por: Cao, Ling, et al.
Publicado: (2019)